STOUGHTON, Mass. (AP) — STOUGHTON, Mass. (AP) — Collegium Pharmaceutical Inc. (COLL) on Thursday reported third-quarter earnings of $9.3 million.

On a per-share basis, the Stoughton, Massachusetts-based company said it had profit of 27 cents. Earnings, adjusted for one-time gains and costs, came to $1.61 per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.66 per share.

The specialty pharmaceutical company posted revenue of $159.3 million in the period, also falling short of Street forecasts. Four analysts surveyed by Zacks expected $160 million.

Collegium Pharmaceutical expects full-year revenue in the range of $620 million to $635 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL